English
|
Spanish
Supporting oncology professionals through education
Login
Register
The content on this site is intended for healthcare professionals only
Menu
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
News
Latest news
Sign up for news alerts
Submit your news
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Journal information
Journal home
Charges
Editorial board
Founding editors
Editor-in-chief
Contact us
Author information
Submit article
Author guidelines
Editorial policies
Copyright information
Why publish with us
Reviewer information
Reviewer guidelines
Memberships
Videos
Recent videos
Sign up
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Conferences
Latest conferences
Sign up for latest coverage
Submit your event
About
e
cancer
About
e
cancer
Our founders
Funding statement
Contact us
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+
-
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
Costs of licensing clinical trials
Share :
ECCO 15 - ESMO 34
Please rate this video
The information in this video was of interest to me
The information in this video is likely to improve my clinical practice or research
I would recommend this video to my colleagues
Published:
3 Nov 2009
Views:
10275
Rating:
Save
Rate video
Prof. John Smyth - Assistant Principal Cancer Research Development, University of Edinburgh
Discusses the issue of the cost of licensing trials with managing editor Professor Gordon McVie, at ECCO 15 - ESMO 34, Berlin, 2009.
Categories:
Drug development
Related Videos
TP53 mutations are linked to unfavourable prognosis in chronic lymphocytic...
Dr Consuelo Bertossi - University Hospital of Ulm, Ulm, Germany
27 Jun 2024
Abemaciclib and fulvestrant show improved efficacy in HR+, HER2- advanced...
Dr Kevin Kalinsky - Winship Cancer Institute, Georgia, USA
26 Jun 2024
Isa-VCd induction in NDMM patients with severe renal impairment show no new...
Prof Evangelos Terpos - University of Athens, School of Medicine, Athens, Greece
26 Jun 2024
A patient-reported questionnnaire may eliminate the need for an ophthalmic exam...
Prof Evangelos Terpos - University of Athens, School of Medicine, Athens, Greece
26 Jun 2024
ASCO 2024: Lung cancer highlights
Dr Antonio Passaro, Dr Matthew Krebs, Prof Raffaele Califano, Prof Nicolas...
26 Jun 2024
EHA 2024: Multiple myeloma roundup
Dr Claudio Cerchione - IRCCS, Meldola, Italy
26 Jun 2024
ATRA-ATO regimen with idarubicin could become the new standard of care in high...
Dr Uwe Platzbecker - University Hospital Leipzig, Leipzig, Germany
25 Jun 2024
Belantamab mafodotin, pomalidomide and dexamethasone shows superior efficacy in...
Prof Meletios Dimopoulos - University of Athens, Athens, Greece
24 Jun 2024
More effective treatment options required for patients with MM post...
Dr Claudio Cerchione - IRCCS, Meldola, Italy
24 Jun 2024
More from
e
cancer